ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,408.90
0.36%
S&P ASX All Technology
3,893.00
0.20%
Brent Oil
77.275
0.12%
US Dollar vs AUD
1.59005
0.41%
Bitcoin
100,510.59
-3.97%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. GenSight Biologics S.A. (SIGHT) Share Price

GenSight Biologics S.A.

GenSight Biologics S.A. (SIGHT)

EU
0.284
-0.0005
( -0.18% )
Updated: 00:44:58
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.284
Bid
0.2805
Offer
0.284
Volume
72,981
0.2785 Day's Range 0.289
0.23 52 Week Range 0.598
Market Cap
22.257M
Previous Close
0.2845
Open
0.289
Last Trade
1095
@
0.284
Last Trade Time
01:14:59
Financial Volume
-
VWAP
-
Average Volume (3m)
293,357
Shares Outstanding
78,370,724
Dividend Yield
-
PE Ratio
-0.84
Earnings Per Share (EPS)
-0.33
Revenue
2.96M
Net Profit
-26.22M

About GenSight Biologics S.A.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.gensight-biologics.com
Headquarters
Paris, Paris, Fra
Founded
-
GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker SIGHT. The last closing price for GenSight Biologics was 0.28 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.23 € to 0.598 €.

GenSight Biologics currently has 78,370,724 shares in issue. The market capitalisation of GenSight Biologics is 22.30 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.84.

Ask ADVFN Intelligence (AI)

SIGHT Latest News

More News

GenSight Biologics announces a financing for an amount of c. €1.5 million from existing investors

THIS PRESS RELEASE IS NOT BEING MADE IN AND COPIES OF IT MAY NOT BE DISTRIBUTED OR SENT, DIRECTLY OR INDIRECTLY, INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA Regulatory News:...

25 December 2024
Business Wire

GenSight Biologics announces a financing for an amount of c. €2.8 million from existing investors

Regulatory News: This press release is not being made in and copies of It may not be distributed or sent, directly or indirectly, into the United States, Canada, South Africa, Japan or...

02 November 2024
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News : GENSIGHT BIOLOGICS (Paris:SIGHT) : (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

02 December 2023
Business Wire

GenSight Biologics : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GenSight Biologics (Paris:SIGHT) (Code ISIN : FR0013183985): Date Nombre d’actions composant le capital Nombre de droits de vote...

05 July 2022
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): Date Nombre d’actions composant le capital Nombre de droits de vote brut1 Nombre de droits de...

02 June 2022
Business Wire

GENSIGHT BIOLOGICS: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS  (Paris:SIGHT): (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

14 April 2022
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

02 February 2022
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

02 December 2021
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

16 November 2021
Business Wire

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

01 October 2021
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00150.5309734513270.28250.29050.271935810.2789242DE
40.0082.898550724640.2760.2980.2631616720.27804627DE
12-0.036-11.250.320.3740.232933570.31250063DE
26-0.038-11.8012422360.3220.4960.233466430.35325243DE
52-0.1235-30.30674846630.40750.5980.232386960.36598459DE
156-3.766-92.9876543214.054.5880.232081411.18712622DE
260-3.346-92.17630853993.639.6950.232710683.15571111DE

SIGHT - Frequently Asked Questions (FAQ)

What is the current GenSight Biologics share price?
The current share price of GenSight Biologics is 0.284 €
How many GenSight Biologics shares are in issue?
GenSight Biologics has 78,370,724 shares in issue
What is the market cap of GenSight Biologics?
The market capitalisation of GenSight Biologics is EUR 22.3M
What is the 1 year trading range for GenSight Biologics share price?
GenSight Biologics has traded in the range of 0.23 € to 0.598 € during the past year
What is the PE ratio of GenSight Biologics?
The price to earnings ratio of GenSight Biologics is -0.84
What is the cash to sales ratio of GenSight Biologics?
The cash to sales ratio of GenSight Biologics is 7.41
What is the reporting currency for GenSight Biologics?
GenSight Biologics reports financial results in EUR
What is the latest annual turnover for GenSight Biologics?
The latest annual turnover of GenSight Biologics is EUR 2.96M
What is the latest annual profit for GenSight Biologics?
The latest annual profit of GenSight Biologics is EUR -26.22M
What is the registered address of GenSight Biologics?
The registered address for GenSight Biologics is 74, RUE DU FAUBOURG SAINT-ANTOINE, PARIS, PARIS, 75012
What is the GenSight Biologics website address?
The website address for GenSight Biologics is www.gensight-biologics.com
Which industry sector does GenSight Biologics operate in?
GenSight Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DMSBSDiagnostic Medical Systems
0.0065 €
(44.44%)
2.05k
ALTROTronic s Microsystems
5.35 €
(37.18%)
41
VACBSPierre & Vacances
0.066 €
(26.92%)
63.93k
ALNMRNamR SA
0.43 €
(25.00%)
48.93k
ALAGOEPango SA
0.2015 €
(15.27%)
5.81M
BIODSBiosynex DS
0.0574 €
(-48.75%)
50.77k
DRVDSDrone Volt DS
0.0004 €
(-33.33%)
688.45k
MLSMLSmalto
0.0155 €
(-24.39%)
50
ALALOAcheterLouerFR
0.04 €
(-22.33%)
345.18k
ALARFAdeunis
0.762 €
(-17.17%)
290
ATOAtos SE
0.0022 €
(4.76%)
571.45M
BCPBanco Comercial Portugues SA
0.5054 €
(-1.94%)
44.26M
ALCYBCybergun
0.0001 €
(0.00%)
16.11M
ALVERVergnet
0.0014 €
(0.00%)
8.4M
ALADOAdomos
0.0002 €
(0.00%)
5.95M

Discussion

View Full Feed
somberfox somberfox 3 minutes ago
News is cooking and all, but it summarizes we don't have anything to look forward to until December now. Roughly.
CLNV
koolmc koolmc 3 minutes ago
deepseek pushing ai plays down
SMCI
prototype_101 prototype_101 4 minutes ago
20 MILLION Shorts Covering Deadline Established June 2025, the gauntlet was put down with the issuance of the new CEO and President Incentive Options being FULLY VESTED in 6 months or June of 2025, this is an UNPRECEDENTED MOVE in the entire history of LWLG!! Normally these types of Incentive Compen
LWLG
sirant sirant 4 minutes ago
Exciting times coming!!!! JMHO 


$MCIC TO PLUTO AND BEYOND $$$$
MCIC
cottonmather cottonmather 4 minutes ago
US Dollar gettin' smacked around but metal manipulation is winning.
Smartypants2 Smartypants2 4 minutes ago
The "very good reason" was greed, pure and simple! They thought they could get a better merger deal somewhere else (but the hot VTOL market had cooled off), so they tried to leave XERI holding the bag for the Auctus loan, which XERI only took to pay for the development of the TriFan 600! Then they u
XERI
L8TR L8TR 4 minutes ago
GWAV AI news out💎
GWAV
jammy32 jammy32 4 minutes ago
What a blood bath. Wow
NVDA
scortech scortech 4 minutes ago
Probably most trading in this is between MM's. Most retail is holding, Flippers to schized out
to trade this.
This seems to trade parallel to this boards sentiment.
JMO
CGAC
fung_derf fung_derf 4 minutes ago
Very interesting and something I've never considered, the replacement of fire trucks.
Well first off, its a private company, so the invest you need to meet certain criteria.
OK, looking further, American Industrial Partners is private, but REV is public $REVG.
This is one heck
REVG
jordan95 jordan95 4 minutes ago
Sorry new to trading and behind on terminology 
ASII
weedtrader420 weedtrader420 4 minutes ago
The fed not lowering rates. if he’s unchanged, he should be fired.
BTCUSD
Hoskuld Hoskuld 4 minutes ago
They are different models - they train differently and have different strengths (as well as sharing some.) DeepSeek is also tweeted politically - for example, ask it about Tiananmen Square or Taiwan and you will get answers that line up with the CCP's official line.
AVXL
fliper fliper 4 minutes ago
DGWR .0175 undervalued after news Fri. jmho
Nice chart and float too
DGWR
georgie18 georgie18 4 minutes ago
Nice news on WIMI...🥳
WIMI
Bubae Bubae 4 minutes ago
uh, oh. someone is being played. 😆 Let the games begin.
Saw the message but only have a free acct.... VeronicaFox
RDAR
L8TR L8TR 4 minutes ago
GWAV AI news out💎
GWAV
glenn1919 glenn1919 5 minutes ago
WIMI...................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p86431144783
MULN WIMI
GARYM1 GARYM1 5 minutes ago
Yp I realize I can come across as single minded and repetitive but who amongst us doesn't want the shareprice to move up.
The problem as I see it is that s7 makes changes in management aswell as thru out company ranks yet nothing ever changes to effect the shareprice.
Industry leading
SEV
ChangnoiPlaza ChangnoiPlaza 5 minutes ago
U ask the wrong question 🤣
COOP
mailman69 mailman69 5 minutes ago
You know that the Tariff idea was tried two times before in The early 1900s in both times caused the depression in high unemployment and higher costs. Look up your history eight dictatorship to benefit the rich not the average person.
INQD
sirant sirant 5 minutes ago
GOOD MORNING EVERYONE 

GO $MCIC 
MCIC
zab zab 5 minutes ago
Trump is never responsible for anything,  that's why his supporters like him.
drkazmd65 drkazmd65 5 minutes ago
Another clear-as-mud Diwan PR.Agreed
NNVC
Investor2014 Investor2014 5 minutes ago
As I said and now quote:
Our success depends in large part on our ability to obtain and maintain protection of our intellectual property, particularly patents, in the United States and other countries with respect to our product candidates and technology. We seek to protect our proprietary po
AVXL

Your Recent History

EU
SIGHT
GenSight Biologics
BOV
BBDC3R
BRADESCO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads